Effect of Dialysis Membranes on Inflammatory and Immune Processes in Hemodialysis

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions
Kidney FailureRenal Insufficiency, ChronicDialysis Related Complication
Interventions
DEVICE

Medium cut-off

"All the dialysis sessions in this arm will be performed with the medium cut-off membrane (MCO) manufactured by Baxter International Corp. membrane for three months. This membrane will exclusively be used in hemodialysis. After third month, all patients will be switched to high-flux membrane manufactured by Fresenius.~Modalities of hemodialysis : Blood flow: 300-400 mL/min; Dialysate flow: 500-800 mL/min"

DEVICE

High-Flux

"All the dialysis sessions in this arm will be performed with the high-flux membrane manufactured by Fresenius for three months. This membrane will exclusively be used in hemodialysis. After third month, all patients will be switched to MCO manufactured by Baxter International Corp.~Modalities of hemodialysis : Blood flow: 300-400 mL/min; Dialysate flow: 500-800 mL/min"

Trial Locations (1)

Unknown

Sisli Hamidiye Etfal Training and Research Hospital, Istanbul

All Listed Sponsors
lead

Sisli Hamidiye Etfal Training and Research Hospital

OTHER

NCT03836508 - Effect of Dialysis Membranes on Inflammatory and Immune Processes in Hemodialysis | Biotech Hunter | Biotech Hunter